ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Sight Sciences, Inc. (SGHT) stock surged +3.76%, trading at $2.76 on NASDAQ, up from the previous close of $2.66. The stock opened at $2.61, fluctuating between $2.48 and $2.78 in the recent session.
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Employees | 216 |
Beta | 2.45 |
Sales or Revenue | $81.06M |
5Y Sales Change% | 6.128% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |